Chemotherapy of acute myeloblastic leukaemia with DAM regimen.
Bangladesh Med Res Counc Bull
;
1997 Dec; 23(3): 82-6
Artículo
en Inglés
| IMSEAR
| ID: sea-470
ABSTRACT
32 patients of denovo-ANLL were treated with Doxorubicin, Ara-C and 6-Mercaptopurine (DAM) regimen. Remission induction was instituted with 1-3 cycles of DAM regimen and maintenance was given by 6-MP continuously with intermittent DA (1,5) regimen. In the remission induction, Doxorubicin 30 mg/m2 for 3 days, Ara-C 150 mg/m2 for 5 days and 6-Mp 100 mg/m2 daily was given. Complete remission (CR) was observed in 60% cases. The probability of 2 years disease-free survival of patients with complete remission is 56.73%.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Recuento de Células Sanguíneas
/
Inducción de Remisión
/
Femenino
/
Humanos
/
Masculino
/
Esquema de Medicación
/
Leucemia Mieloide Aguda
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Doxorrubicina
/
Supervivencia sin Enfermedad
Idioma:
Inglés
Revista:
Bangladesh Med Res Counc Bull
Año:
1997
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS